---
figid: PMC7383499__PCMR-33-334-g006
figtitle: Graphical summary of signaling in NRAS‐mutant melanoma cells treated with
  trametinib
organisms:
- Homo sapiens
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC7383499
filename: PCMR-33-334-g006.jpg
figlink: pmc/articles/PMC7383499/figure/pcmr12825-fig-0006/
number: F6
caption: Graphical summary of signaling in NRAS‐mutant melanoma cells treated with
  trametinib. FBXO42 KO in NRAS‐mutant melanoma cells leads trametinib resistance.
  This occurs by activation of the MAPK pathway together with TAK1 signaling through
  p38 activation. The combination of trametinib together with the TAK1 inhibitor,
  takinib, inhibits cellular proliferation
papertitle: A genome‐wide CRISPR screen identifies FBXO42 involvement in resistance
  toward MEK inhibition in NRAS‐mutant melanoma.
reftext: Adi Nagler, et al. Pigment Cell Melanoma Res. 2020 Mar;33(2):334-344.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9174625
figid_alias: PMC7383499__F6
figtype: Figure
redirect_from: /figures/PMC7383499__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7383499__PCMR-33-334-g006.html
  '@type': Dataset
  description: Graphical summary of signaling in NRAS‐mutant melanoma cells treated
    with trametinib. FBXO42 KO in NRAS‐mutant melanoma cells leads trametinib resistance.
    This occurs by activation of the MAPK pathway together with TAK1 signaling through
    p38 activation. The combination of trametinib together with the TAK1 inhibitor,
    takinib, inhibits cellular proliferation
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - KRAS
  - HRAS
  - NRAS
  - FBXO42
  - MAP3K7
  - NR2C2
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - ras
  - Ras64B
  - Ras85D
  - ko
  - Fbxo42
  - Tak1
  - Dsor1
  - Mtk
  - Erk7
  - rl
  - Trametinib
---
